Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Return on Assets (2018 - 2025)

Autolus Therapeutics' Return on Assets history spans 8 years, with the latest figure at 0.46% for Q4 2025.

  • For Q4 2025, Return on Assets fell 19.0% year-over-year to 0.46%; the TTM value through Dec 2025 reached 0.46%, down 19.0%, while the annual FY2025 figure was 0.42%, 4.0% down from the prior year.
  • Return on Assets reached 0.46% in Q4 2025 per AUTL's latest filing, down from 0.33% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.06% in Q4 2021 to a low of 0.53% in Q4 2023.
  • Average Return on Assets over 5 years is 0.32%, with a median of 0.32% recorded in 2024.
  • Peak YoY movement for Return on Assets: crashed -34bps in 2022, then grew 26bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.06% in 2021, then plummeted by -569bps to 0.39% in 2022, then tumbled by -35bps to 0.53% in 2023, then soared by 49bps to 0.27% in 2024, then plummeted by -68bps to 0.46% in 2025.
  • Per Business Quant, the three most recent readings for AUTL's Return on Assets are 0.46% (Q4 2025), 0.33% (Q3 2025), and 0.31% (Q2 2025).